Is Aton (EPA:ALTAO) Using Too Much Debt?
Dec 19
Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedDec 24, 2025
DataAggregated Company Financials
Companies22
- 7D21.0%
- 3M50.1%
- 1Y392.7%
- YTD368.1%
In the last week, the Biotech industry is up 8.5%, with ABIVAX Société Anonyme up 11%. During this same period, the Valerio Therapeutics Société anonyme underperformed, falling 23%. In the last 12 months, the industry was up 383%. Looking forward, earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Dec 2025 | €12.0b | €641.2m | -€693,363,976.30 | 10.1x | -17.3x | 18.7x |
| Fri, 21 Nov 2025 | €2.5b | €653.9m | -€396,855,260.93 | 10.6x | -6.3x | 3.8x |
| Sun, 19 Oct 2025 | €2.6b | €645.0m | -€429,377,777.01 | 9.9x | -6x | 4x |
| Tue, 16 Sep 2025 | €2.5b | €681.4m | -€466,830,969.11 | 14x | -5.3x | 3.6x |
| Thu, 14 Aug 2025 | €2.5b | €673.9m | -€445,469,384.02 | 15.4x | -5.7x | 3.7x |
| Sat, 12 Jul 2025 | €1.9b | €655.4m | -€451,572,124.85 | 16.4x | -4.3x | 3x |
| Mon, 09 Jun 2025 | €2.1b | €667.9m | -€498,616,348.87 | 17.2x | -4.1x | 3.1x |
| Wed, 07 May 2025 | €2.5b | €653.2m | -€593,541,212.39 | 39.5x | -4.2x | 3.9x |
| Fri, 04 Apr 2025 | €2.3b | €657.7m | -€554,388,149.57 | 13.9x | -4.1x | 3.5x |
| Sun, 02 Mar 2025 | €2.5b | €650.5m | -€527,725,175.17 | 16.6x | -4.7x | 3.8x |
| Tue, 28 Jan 2025 | €2.3b | €649.5m | -€524,666,485.14 | 15.8x | -4.4x | 3.5x |
| Thu, 26 Dec 2024 | €2.3b | €654.8m | -€550,010,237.87 | 17.3x | -4.2x | 3.5x |
| Sat, 23 Nov 2024 | €2.5b | €654.9m | -€550,258,445.18 | 18x | -4.5x | 3.8x |
| Mon, 21 Oct 2024 | €2.8b | €627.7m | -€512,418,851.19 | 19.3x | -5.5x | 4.5x |
| Wed, 18 Sep 2024 | €3.0b | €496.9m | -€635,764,585.50 | 36.4x | -4.7x | 6x |
| Fri, 16 Aug 2024 | €3.0b | €517.1m | -€573,205,025.48 | 37.1x | -5.3x | 5.9x |
| Sun, 14 Jul 2024 | €3.0b | €511.7m | -€566,118,402.03 | 26.9x | -5.3x | 5.9x |
| Tue, 11 Jun 2024 | €3.4b | €509.9m | -€565,716,429.40 | 28.8x | -6x | 6.7x |
| Thu, 09 May 2024 | €3.2b | €502.8m | -€594,371,083.75 | 28x | -5.4x | 6.4x |
| Sat, 06 Apr 2024 | €3.2b | €511.5m | -€567,567,497.12 | 22.2x | -5.7x | 6.3x |
| Mon, 04 Mar 2024 | €3.1b | €558.7m | -€673,952,607.81 | 21.6x | -4.6x | 5.5x |
| Wed, 31 Jan 2024 | €3.2b | €594.6m | -€684,984,332.00 | 21.4x | -4.7x | 5.4x |
| Fri, 29 Dec 2023 | €3.3b | €593.9m | -€681,170,768.00 | 23.1x | -4.8x | 5.5x |
| Sun, 26 Nov 2023 | €3.2b | €594.2m | -€683,014,791.00 | 22.5x | -4.7x | 5.4x |
| Tue, 24 Oct 2023 | €3.0b | €806.4m | -€590,607,497.00 | 20.8x | -5.1x | 3.7x |
| Thu, 21 Sep 2023 | €3.8b | €813.3m | -€732,805,005.00 | 24.6x | -5.2x | 4.7x |
| Sat, 19 Aug 2023 | €3.6b | €818.1m | -€726,312,722.00 | 23.6x | -5x | 4.5x |
| Mon, 17 Jul 2023 | €3.8b | €817.1m | -€732,039,089.00 | 26.3x | -5.1x | 4.6x |
| Wed, 14 Jun 2023 | €3.8b | €820.5m | -€743,666,459.00 | 26.4x | -5.1x | 4.6x |
| Fri, 12 May 2023 | €3.7b | €831.4m | -€759,781,361.00 | 25.3x | -4.8x | 4.4x |
| Sun, 09 Apr 2023 | €3.5b | €946.2m | -€695,412,143.00 | 18.5x | -5x | 3.7x |
| Tue, 07 Mar 2023 | €3.6b | €1.0b | -€481,022,666.00 | 10.6x | -7.4x | 3.5x |
| Thu, 02 Feb 2023 | €3.7b | €1.0b | -€453,673,696.00 | 11.8x | -8.1x | 3.5x |
| Sat, 31 Dec 2022 | €3.6b | €1.0b | -€454,883,490.00 | 11.7x | -7.9x | 3.5x |
Price to Earnings Ratio
-7.9x
Current Industry PE
- Investors are optimistic on the French Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 18.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 15% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | -0.28% | |
| Healthcare | 0.28% | |
| Biotech | 21.00% | |
| Biotech | 21.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | €119.80 | 27.3% +€2.0b | 1,592.1% | PS1755.6x | |
| ALCLS Cellectis | €4.10 | 19.5% +€48.5m | 177.0% | PS4.2x | |
| NANO Nanobiotix | €19.88 | 4.4% +€40.5m | 564.9% | PS94.4x | |
| VLA Valneva | €3.65 | 2.4% +€14.4m | 83.7% | PS3.5x | |
| DBV DBV Technologies | €3.13 | 2.1% +€11.7m | 405.7% | PS120.4x |